nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Another year
|
Cavalli, F. |
|
|
9 |
1 |
p. 7 |
artikel |
2 |
Another year
|
F. Cavalli |
|
1998 |
9 |
1 |
p. 7-7 1 p. |
artikel |
3 |
A phase I and pharmacologic study of DMP 840 administered by 24-hour infusion* * Presented in part at the 31st Annual Meeting of the American Society of Clinical Oncology, Los Angeles, CA, USA, 20–23 May 1995.
|
O’Reilly, S. |
|
|
9 |
1 |
p. 101-104 |
artikel |
4 |
A phase I trial of human corticotropin-releasing factor (hCRF) in patients with peritumoral brain edema
|
Villalona-Calero, M.A. |
|
|
9 |
1 |
p. 71-77 |
artikel |
5 |
A phase I trial of human corticotropin-releasing factor (hCRF) inpatients with peritumoral brain edema
|
M. A. Villalona-Calero |
|
1998 |
9 |
1 |
p. 71-77 7 p. |
artikel |
6 |
Awards, appointments
|
|
|
|
9 |
1 |
p. 5 |
artikel |
7 |
Blood stem cell transplantation. Cancer treatment andresearch. J.N. Winter (ed).
|
M. Ghielmini |
|
1998 |
9 |
1 |
p. 8-8 1 p. |
artikel |
8 |
Book review
|
Neuenschwander, H. |
|
|
9 |
1 |
p. 120 |
artikel |
9 |
Book review
|
Ghielmini, M. |
|
|
9 |
1 |
p. 8 |
artikel |
10 |
Carboplatin versus cisplatin in solid tumors: An analysis of the literature
|
Lokich, J. |
|
|
9 |
1 |
p. 13-21 |
artikel |
11 |
Carboplatin versus cisplatin in solid tumors: An analysis of theliterature
|
J. Lokich |
|
1998 |
9 |
1 |
p. 13-21 9 p. |
artikel |
12 |
CD44v6 is not a prognostic factor in primary breast cancer
|
Jansen, R.H.L. |
|
|
9 |
1 |
p. 109-111 |
artikel |
13 |
CD44v6 is not a prognostic factor in primary breast cancer
|
R. H. L. Jansen |
|
1998 |
9 |
1 |
p. 109-111 3 p. |
artikel |
14 |
Consensus conference on high-dose therapy with hematopoietic stem celltransplantation in diffuse large-cell lymphoma
|
A. Kessinger |
|
1998 |
9 |
1 |
p. 23-30 8 p. |
artikel |
15 |
Contents of the next issue
|
|
|
|
9 |
1 |
p. vii |
artikel |
16 |
Contents of the next issue
|
|
|
1998 |
9 |
1 |
p. 0-0 1 p. |
artikel |
17 |
Copyright
|
|
|
|
9 |
1 |
p. v |
artikel |
18 |
Detection of chromosome 3p alterations in serum DNA of non-small-cell lung cancer patients
|
Sánchez-Céspedes, M. |
|
|
9 |
1 |
p. 113-116 |
artikel |
19 |
Detection of chromosome 3p alterations in serum DNA of non-small-celllung cancer patients
|
M. Sánchez-Céspedes |
|
1998 |
9 |
1 |
p. 113-116 4 p. |
artikel |
20 |
Editorial board
|
|
|
|
9 |
1 |
p. vi |
artikel |
21 |
Efficacy and safety of the paclitaxel and carboplatin combination in patients with previously treated advanced ovarian carcinoma
|
Guastalla, J.P. |
|
|
9 |
1 |
p. 37-43 |
artikel |
22 |
Equianalgesic dose/ratio between methadone and other opioid agonists in cancer pain: Comparison of two clinical experiences
|
Ripamonti, C. |
|
|
9 |
1 |
p. 79-83 |
artikel |
23 |
Equianalgesic dose/ratio between methadone and other opioid agonists incancer pain: Comparison of two clinical experiences
|
C. Ripamonti |
|
1998 |
9 |
1 |
p. 79-83 5 p. |
artikel |
24 |
Ethics in Hospice care: Challenges to Hospice valuesin a changing health care environment. B. Jennings (ed).
|
H. Neuenschwander |
|
1998 |
9 |
1 |
p. 120-120 1 p. |
artikel |
25 |
Freys syndrome after cisplatin-based chemotherapy for testicularteratoma
|
P. Beale |
|
1998 |
9 |
1 |
p. 118-119 2 p. |
artikel |
26 |
Frey’s syndrome after cisplatin-based chemotherapy for testicular teratoma
|
Beale, P. |
|
|
9 |
1 |
p. 118-119 |
artikel |
27 |
G-CSF prevents the suppression of bone marrow hematopoiesis induced by IL-12 and augments its antitumor activity in a melanoma model in mice
|
Gołąb, I. |
|
|
9 |
1 |
p. 63-69 |
artikel |
28 |
G-Csf prevents the suppression of bone marrow hematopoiesis induced byIL-12 and augments its antitumor activity in a melanoma model in mice
|
J. Gob |
|
1998 |
9 |
1 |
p. 63-69 7 p. |
artikel |
29 |
German oncology research shaken by fraud case
|
Abbott, Alison |
|
|
9 |
1 |
p. 1-2 |
artikel |
30 |
German oncology research shaken by fraud case; Hemato-oncologists meetagain at Airlie House; Hemato-oncology refashioned in the NeueBundesländer; Awards, appointments; Perhaps not everyone knows that...;Climate change
|
|
|
1998 |
9 |
1 |
p. 1-6 6 p. |
artikel |
31 |
Hemato-oncologists meet again at Airlie House
|
|
|
|
9 |
1 |
p. 2-4 |
artikel |
32 |
Hemato-oncology refashioned in the ‘Neue Bundesländer’
|
|
|
|
9 |
1 |
p. 4-5 |
artikel |
33 |
High-dose chemotherapy and hematopoietic stem cell transplantation forrelapsed or refractory diffuse large-cell non-Hodgkins lymphoma
|
J. M. Vose |
|
1998 |
9 |
1 |
p. 1-3 3 p. |
artikel |
34 |
High-dose therapy followed by stem cell transplantation in partialresponse after first-line induction therapy for aggressive non-Hodgkinslymphoma
|
C. Haioun |
|
1998 |
9 |
1 |
p. 5-8 4 p. |
artikel |
35 |
High-dose therapy for diffuse large-cell lymphoma in firstremission
|
A. R. Perry |
|
1998 |
9 |
1 |
p. 9-14 6 p. |
artikel |
36 |
Immunotherapy in conjunction with autologous and allogeneic blood ormarrow transplantation in lymphoma
|
S. Slavin |
|
1998 |
9 |
1 |
p. 31-39 9 p. |
artikel |
37 |
Incidence, mortality and survival from prostate cancer in Vaud and Neuchâtel, Switzerland, 1974–1994
|
Levi, F. |
|
|
9 |
1 |
p. 31-35 |
artikel |
38 |
Incidence, mortality and survival from prostate cancer in Vaud andNeuchâtel, Switzerland, 19741994
|
F. Levi |
|
1998 |
9 |
1 |
p. 31-35 5 p. |
artikel |
39 |
Instructions to authors
|
|
|
|
9 |
1 |
p. 121-122 |
artikel |
40 |
In this Issue
|
|
|
|
9 |
1 |
p. vii |
artikel |
41 |
In this issue
|
|
|
1998 |
9 |
1 |
p. 0-0 1 p. |
artikel |
42 |
Management of an isolated thymic mass after primary therapy for lymphoma
|
Anchisi, S. |
|
|
9 |
1 |
p. 95-100 |
artikel |
43 |
Management of an isolated thymic mass after primary therapy forlymphoma
|
S. Anchisi |
|
1998 |
9 |
1 |
p. 95-100 6 p. |
artikel |
44 |
No evidence of significant activity of the multidrug resistance gene product in primary human breast cancer
|
Hegewisch-Becker, S. |
|
|
9 |
1 |
p. 85-93 |
artikel |
45 |
No evidence of significant activity of the multidrug resistance geneproduct in primary human breast cancer
|
S. Hegewisch-Becker |
|
1998 |
9 |
1 |
p. 85-93 9 p. |
artikel |
46 |
Oxaliplatin as single agent in previously untreated colorectal carcinoma patients: A phase II multicentric study
|
Díaz-Rubio, E. |
|
|
9 |
1 |
p. 105-108 |
artikel |
47 |
Oxaliplatin as single agent in previously untreated colorectal carcinomapatients: A phase II multicentric study
|
E. Díaz-Rubio |
|
1998 |
9 |
1 |
p. 105-108 4 p. |
artikel |
48 |
Paclitaxel in combination with weekly 24-hour infusional 5-fluorouracil plus leucovorin in the second-line treatment of metastatic breast cancer: Results of a phase II study
|
Klaassen, U. |
|
|
9 |
1 |
p. 45-50 |
artikel |
49 |
Paclitaxel in combination with weekly 24-hour infusional 5-fluorouracilplus leucovorin in the second-line treatment of metastatic breast cancer:Results of a phase II study
|
U. Klaassen |
|
1998 |
9 |
1 |
p. 45-50 6 p. |
artikel |
50 |
Perhaps not everyone knows that…
|
|
|
|
9 |
1 |
p. 5-6 |
artikel |
51 |
Prevention of hepatitis development by interferon-alpha in HBV carriers treated with intensive chemotherapy: A pilot study
|
Kumagai, K. |
|
|
9 |
1 |
p. 117-118 |
artikel |
52 |
Prevention of hepatitis development by interferon-alpha in HBV carrierstreated with intensive chemotherapy: A pilot study
|
K. Kumagai |
|
1998 |
9 |
1 |
p. 117-118 2 p. |
artikel |
53 |
Prostate cancer: Screening or watchful waiting?
|
Weyler, J. |
|
|
9 |
1 |
p. 9-11 |
artikel |
54 |
Prostate cancer: Screening or watchful waiting?
|
J. Weyler |
|
1998 |
9 |
1 |
p. 9-11 3 p. |
artikel |
55 |
Rearrangements of bcl-6, bcl-2, c-myc and 6q deletion in B-diffuselarge-cell lymphoma: Clinical relevance in 71 patients
|
U. Vitolo |
|
1998 |
9 |
1 |
p. 55-61 7 p. |
artikel |
56 |
Rearrangements of bcl-6, bcl-2, c-myc and 6q deletion in B-diffuse large-cell lymphoma: Clinical relevance in 71 patients
|
Vitolo, U. |
|
|
9 |
1 |
p. 55-61 |
artikel |
57 |
Recent advances in the molecular genetics of cancer
|
Spataro, V. |
|
|
9 |
1 |
p. 23-29 |
artikel |
58 |
Selection and immunomagnetic purging of peripheral blood CD34+ cells for autologous transplantation in B-cell non-Hodgkin’s lymphomas
|
Pichert, G. |
|
|
9 |
1 |
p. 51-54 |
artikel |
59 |
Suggested questions for the jury
|
M. A. Shipp |
|
1998 |
9 |
1 |
p. 47-47 1 p. |
artikel |
60 |
Table of Contents
|
|
|
|
9 |
1 |
p. iv-v |
artikel |
61 |
Title Page
|
|
|
|
9 |
1 |
p. iii |
artikel |
62 |
Tumor vaccination strategies combined with autologous peripheral stemcell transplantation
|
L. W. Kwak |
|
1998 |
9 |
1 |
p. 41-46 6 p. |
artikel |